Search Results

You are looking at 31 - 40 of 125 items for :

  • All content x
Clear All

Irodalom 1 Lin P, Owens R, Tricot G, et al. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. American Journal of Clinical Pathology 2004

Restricted access
Orvosi Hetilap
Authors: Orsolya Németh, Beáta Tapasztó, Sándor Tar, Viktória Szabó, Zoltán Zsolt Nagy, Jeannette Tóth, Aryan Hamed, Gábor Mikala, and Nóra Szentmáry

References 1 Nagy Zs. Multiple myeloma and other plasma cell dyscrasias. [Mielóma multiplex és egyéb plazmasejtes diszkráziák.] Magy Onkol. 2016; 60

Open access

, Bross PF , Farrell AT , Pazdur R : Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy . The Oncologist 8 , 508 – 513 ( 2003 ) 2

Open access
Orvosi Hetilap
Authors: Dóra Bajcsi, Kypros Constantinou, László Krenács, Zsolt Barabás, Szabolcs Molnár, Szabolcs Nyiraty, György Ábrahám, and Béla Iványi

Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014; 15: e538– e548. 11

Restricted access

2): 24–25. 5 Marchesi F, Pimpinelli F, Gumenyuk S, et al. Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: a single

Open access
Acta Biologica Hungarica
Authors: Eszter László, P. Kiss, Gabriella Horváth, P. Szakály, Andrea Tamás, and Dóra Reglődi

myeloma kidney injury. Blood 107 , 661–668. Batuman V. Potential protective action of pituitary adenylate cyclase activating polypeptide (PACAP38) on in vitro and in vivo models of

Restricted access
Orvosi Hetilap
Authors: Tamás Nagykálnai and László Landherr

Rosen, L. S., Gordon, D., Kaminski, M., et al.: Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized

Open access
Orvosi Hetilap
Authors: Ágnes Haris, József Arányi, Henrik Braunitzer, Éva Kálmán, Zoltán Merán, Mariann Soltész, and Kálmán Polner

with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre. Nephrol. Dial. Transplant., 2010, 25 , 419–426. Collins G. P. Presentation and

Restricted access

. J Infect Dis. 1987; 156: 471–477. 18 Teh BW, Harrison SJ, Worth LJ, et al. Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort

Open access

Biszfoszfonát-kezelés során fellépő állcsontnecrosis

Gyakorlati útmutató a biszfoszfonáttal kezelt betegeknél fellépő osteonecrosis megelőzéséhez és kezeléséhez

Magyar Onkológia
Authors: Enikő Udvardy, Pál Redl, and Ildikó Márton

jaws in myeloma: Time dependent correlation with Aredia and Zometa use Blood 104 216a abstr 756. 6. KL Gebhard

Restricted access